21,282 Adverse Injuries & 93 Deaths Reported to VAERS
Images Are More Powerful than Numbers
“A mother knows better than anyone the real legacy of Gardasil
& Cervarix, the betrayal of public trust, extending from the highest sectors of Government & the Vaccine Industry to the thousands of clinics & hospitals most families depend on, that has cut into the very heart of the community and
devastated the lives of countless young women
before reaching the prime of their lives.
See entire story at http://sanevax.org/blog/?p=2226
Saturday, February 26, 2011
Monday, February 21, 2011
Merck Funded Study States - Gardasil Equally Effective for Males and Females
SANE Vax, Inc. is Concerned about Missing Data in the Reports
The media went wild last week announcing the report published in the Feb. 3 issue of the New England Journal of Medicine, (NEJM) was funded by the vaccine's maker, Merck & Co., 1 stating Gardasil was 90 percent effective in older teenaged boys and young men.
Gardasil was approved for use for boys ages 9 through 26 in 2009 by the U.S. Food and Drug Administration. U.S. Centers for Disease Control and Prevention advisory panel voted against routine use of the vaccine in boys and men.
Am sure the researchers/marketers at Merck decided a study announcing that Gardasil was equally effective in preventing genital warts would increase uptake/sales of the vaccine. This is a marketing tactic – not a study – and not even an independent study.
The study was conducted on 4065 healthy boys and men 16 to 26 years of age, from 18 countries in a randomized, placebo-controlled, double-blind trial at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., The primary efficacy objective was to show that the quadrivalent HPV vaccine reduced the incidence of external genital lesions related to HPV-6, 11, 16, or 18.2.
SANE VAX, Inc. is asking – What about boys ages 9 to 15? Why weren’t they included? By the time a 9 year old reaches the age of 16 – the vaccine will no longer be effective.
SANE Vax wants to know the length of time for the study. Months? Years? Even NEJM does not even report this. Where are the long term results? How can there be any?
Fred Wyand, director of the HPV Resource Center at the American Social Health Association stated; "Studies like this underscore the 'human' in human papillomavirus."3. Well, let’s look at human viruses. They lay dormant, and they mutate. Genital warts come and go in both male and female populations. Viruses are triggered/stimulated by environment and stress – as well as lifestyle. Viral patterns are impossible to predict. The only thing in life that is constant is “change.”
Gardasil is only effective for 5 years. What happens after that? What if the viruses come back in full force? Oh, yeah another vaccine.
Healthy boys? What kind of study is that? Define “healthy.” What about unhealthy boys – boys with pre-existing or a family history of allergies or autoimmune diseases. The same “healthy” demographic was used in the clinical trials for adolescent girls – and there are now 21,292 reported adverse reactions and 93 deaths reported to VAERS.
Why perform a study on another healthy population when the initial study has caused so many injuries to girls ages 9 to 26? SANE Vax Inc. does not think this is science-based medicine at all…. It is more like the fairy tale, “The Emperor has no Clothes.” When are medical consumers and practitioners going to realize that Merck has pulled the wool over our eyes again?
This study would more aptly be titled “One Less Boy to Get Genital Warts.” SANE Vax fears that this campaign will turn into ‘One More Boy Adversely Injured.’ How can the outcome be any different?
SANE Vax Inc. is concerned about the missing data or data not being reported in this study. The line between marketing and science based evidence is getting pretty thin. Medical consumers deserve to have independent studies conducted on the safety and efficacy of any and all medications developed for non-life threatening medical issues. Parents getting the HPV vaccine for their sons need to have the answers to all of these issues for informed consent. The days of blind faith are over.
Sources:
1. New England Journal of Medicine, Feb 3, 2011, Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, http://www.nejm.org/doi/full/10.1056/NEJMoa0909537
Supported by Merck and by grants (M01-RR-00079 and UL1 RR024131, to Dr. Palefsky) from the National Center for Research Resources and by a grant (RO1 CA098803, to Dr. Giuliano) from the National Institutes of Health.
Drs. Giuliano, Ferris, Moreira, Penny, and Palefsky report receiving grant support from Merck, either personally or through their institution; Dr. Penny reports receiving grant support from GlaxoSmithKline; Dr. Goldstone reports receiving grant support from Qiagen; Drs. Giuliano, Ferris, Moreira, Hillman, and Chang report receiving speaking fees or fees for board membership from Merck; Dr. Moi reports that his institution has received funding from Merck; Dr. Penny reports having stock or stock options in AstraZeneca; Dr. Palefsky reports receiving consulting fees from GlaxoSmithKline; Drs. Giuliano, Palefsky, Goldstone, Moreira, Moi, and Chang report receiving travel reimbursement from Merck; Dr. Bryan reports having an approved, filed, or pending patent related to subject matter discussed in this article; and Dr. Bryan, Dr. Marshall, Dr. Vuocolo, Dr. Barr, Dr. Haupt, Mr. Radley, and Dr. Guris are employees of Merck and own Merck stock or stock options. No other potential conflict of interest relevant to this article was reported.
2. New England Journal of Medicine, Feb 3, 2011, Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, http://www.nejm.org/doi/full/10.1056/NEJMoa0909537
3. MedlinePlus, Feb. 2, 2011, Gardasil Vaccine Guards Against HPV in Boys, http://www.nlm.nih.gov/medlineplus/news/fullstory_108399 ...
For more information, visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
The media went wild last week announcing the report published in the Feb. 3 issue of the New England Journal of Medicine, (NEJM) was funded by the vaccine's maker, Merck & Co., 1 stating Gardasil was 90 percent effective in older teenaged boys and young men.
Gardasil was approved for use for boys ages 9 through 26 in 2009 by the U.S. Food and Drug Administration. U.S. Centers for Disease Control and Prevention advisory panel voted against routine use of the vaccine in boys and men.
Am sure the researchers/marketers at Merck decided a study announcing that Gardasil was equally effective in preventing genital warts would increase uptake/sales of the vaccine. This is a marketing tactic – not a study – and not even an independent study.
The study was conducted on 4065 healthy boys and men 16 to 26 years of age, from 18 countries in a randomized, placebo-controlled, double-blind trial at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., The primary efficacy objective was to show that the quadrivalent HPV vaccine reduced the incidence of external genital lesions related to HPV-6, 11, 16, or 18.2.
SANE VAX, Inc. is asking – What about boys ages 9 to 15? Why weren’t they included? By the time a 9 year old reaches the age of 16 – the vaccine will no longer be effective.
SANE Vax wants to know the length of time for the study. Months? Years? Even NEJM does not even report this. Where are the long term results? How can there be any?
Fred Wyand, director of the HPV Resource Center at the American Social Health Association stated; "Studies like this underscore the 'human' in human papillomavirus."3. Well, let’s look at human viruses. They lay dormant, and they mutate. Genital warts come and go in both male and female populations. Viruses are triggered/stimulated by environment and stress – as well as lifestyle. Viral patterns are impossible to predict. The only thing in life that is constant is “change.”
Gardasil is only effective for 5 years. What happens after that? What if the viruses come back in full force? Oh, yeah another vaccine.
Healthy boys? What kind of study is that? Define “healthy.” What about unhealthy boys – boys with pre-existing or a family history of allergies or autoimmune diseases. The same “healthy” demographic was used in the clinical trials for adolescent girls – and there are now 21,292 reported adverse reactions and 93 deaths reported to VAERS.
Why perform a study on another healthy population when the initial study has caused so many injuries to girls ages 9 to 26? SANE Vax Inc. does not think this is science-based medicine at all…. It is more like the fairy tale, “The Emperor has no Clothes.” When are medical consumers and practitioners going to realize that Merck has pulled the wool over our eyes again?
This study would more aptly be titled “One Less Boy to Get Genital Warts.” SANE Vax fears that this campaign will turn into ‘One More Boy Adversely Injured.’ How can the outcome be any different?
SANE Vax Inc. is concerned about the missing data or data not being reported in this study. The line between marketing and science based evidence is getting pretty thin. Medical consumers deserve to have independent studies conducted on the safety and efficacy of any and all medications developed for non-life threatening medical issues. Parents getting the HPV vaccine for their sons need to have the answers to all of these issues for informed consent. The days of blind faith are over.
Sources:
1. New England Journal of Medicine, Feb 3, 2011, Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, http://www.nejm.org/doi/full/10.1056/NEJMoa0909537
Supported by Merck and by grants (M01-RR-00079 and UL1 RR024131, to Dr. Palefsky) from the National Center for Research Resources and by a grant (RO1 CA098803, to Dr. Giuliano) from the National Institutes of Health.
Drs. Giuliano, Ferris, Moreira, Penny, and Palefsky report receiving grant support from Merck, either personally or through their institution; Dr. Penny reports receiving grant support from GlaxoSmithKline; Dr. Goldstone reports receiving grant support from Qiagen; Drs. Giuliano, Ferris, Moreira, Hillman, and Chang report receiving speaking fees or fees for board membership from Merck; Dr. Moi reports that his institution has received funding from Merck; Dr. Penny reports having stock or stock options in AstraZeneca; Dr. Palefsky reports receiving consulting fees from GlaxoSmithKline; Drs. Giuliano, Palefsky, Goldstone, Moreira, Moi, and Chang report receiving travel reimbursement from Merck; Dr. Bryan reports having an approved, filed, or pending patent related to subject matter discussed in this article; and Dr. Bryan, Dr. Marshall, Dr. Vuocolo, Dr. Barr, Dr. Haupt, Mr. Radley, and Dr. Guris are employees of Merck and own Merck stock or stock options. No other potential conflict of interest relevant to this article was reported.
2. New England Journal of Medicine, Feb 3, 2011, Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, http://www.nejm.org/doi/full/10.1056/NEJMoa0909537
3. MedlinePlus, Feb. 2, 2011, Gardasil Vaccine Guards Against HPV in Boys, http://www.nlm.nih.gov/medlineplus/news/fullstory_108399 ...
For more information, visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Sunday, February 13, 2011
99 Strains of HPV on the Wall - One MORE GIRL on the Wall
Ninety-nine bottles of beer on the wall, ninety-nine bottles of beer.... Take one down, pass it around, Ninety-eight bottles of beer on the wall.... 99 Strains of HPV on the Wall.... You Take One Down and Pass it Around…. One MORE GIRL on the Wall
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Feb 13, 2011 – By Leslie Carol Botha, Director of SANE VAX, INC.
Ninety-nine bottles of beer on the wall, ninety-nine bottles of beer
Take one down, pass it around, Ninety-eight bottles of beer on the wall.
Sound familiar? 99 Bottles of Beer is a popular traditional U.S. and Canadian song with a repetitive format – easy to memorize - and frequently sung by children on long bus trips, or Scouting outings. The same verse is repeated, each time with one fewer bottle. The song is completed when the singers reach zero.
Could it be that Merck & CO pharmacists are singing 99 Strains of HPV on the Wall as they prepare to manufacture more vaccines targeting more HPV viral strains? And of course the accounting department is humming the same tune as they realize the income potential and enter projected profits from this new revenue stream. And one wonders if Wall Street is also memorizing the song knowing that stock will not only remain stable but potentially soar.
According to an article that appeared in the January 13, 2011 issue of Drug Discovery and Development, Vaccine Markets A Refuge for Big Pharma, http://www.dddmag.com/news-Vaccine-Markets-A-Refuge-for- ... :
…Gardasil, which was approved for the prevention of four strains of HPV (human papillomavirus), is currently being tested for the prevention of nine more strains.
90 Strains of HPV on the Wall
The article also states: “Human vaccines, earlier considered as a low profit yielding business, have transformed into cash cows for global pharmaceutical giants. Patents for human and animal vaccines accepted by European and US patent authorities totaled nearly 250 in 2007. Prophylactic vaccines (intended to prevent cancer from developing in healthy people) represents the biggest earner in the human vaccines market.”
Oh, yes, Big Pharma is singing 99 Strains of HPV on the Wall – all the way to Wall Street.
Meanwhile, SANE Vax, Inc. keeps finding research and documentation on the scientific research behind the vaccines, the faulty trials and the unethical marketing campaigns – that had adolescent girls singing their award –winning “One Less Girl to Get Cervical Cancer” jingle….
Gardasil. Gardasil. Gardasil. Gardasil.
I want to be one less woman who will battle cervical cancer.
One LESS.
One has to admit – the campaign jingle has similar qualities to 99 Bottles of Beer in the Wall – it has a repetitive format and is easy to memorize. Guess Merck’s public relations firm is also singing 99 Strains of HPV on the Wall as they develop more award-winning marketing campaigns.
Unfortunately, one less girl has sadly turned into One More Girl adversely injured. VAERS statistics as of February are: 21,292 girls (20,377) and boys (309) adversely injured, 94 dead; an estimated 1 to 10% of the population reporting.
21,292 HPV Vaccine Adverse Injuries on the Wall - asking when will the jingle end?
Recently, the mother of a 13-year old injured by the vaccine told a SANE Vax member that when she called 1-800 MERCK – the man on the line admitted that not enough clinical trials were conducted on Gardasil and that her daughter was part of a trial. SANE Vax is outraged by this admission. But this is how Pharma operates with all drugs especially for women. Birth control pills, hormone replacement therapy (HRT), and Gardasil are now known as the largest uncontrolled experiments in medical history.
SANE Vax Inc. is determined to prevent Gardasil from being trialed on innocent children. We are proud to be involved in the production of the groundbreaking ONE MORE GIRL documentary along with Truth About Gardasil.org and ThinkExist Productions http://www.kickstarter.com/projects/1995527181/one-more- ....
The time to get involved is now – we need to stop Merck and their 99 Strains of HPV on the Wall thinking until an independent study on the safety and efficacy of Gardasil has been conducted before more HPV-related vaccines are introduced to the market.
Please donate today. The girls injured by the HPV vaccines want to tell their stories to the world to prevent this type of travesty from ever happening again.
99 Strains of HPV on the Wall
You Take One Down and Pass it Around….
One MORE GIRL on the Wall
For more information, visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Feb 13, 2011 – By Leslie Carol Botha, Director of SANE VAX, INC.
Ninety-nine bottles of beer on the wall, ninety-nine bottles of beer
Take one down, pass it around, Ninety-eight bottles of beer on the wall.
Sound familiar? 99 Bottles of Beer is a popular traditional U.S. and Canadian song with a repetitive format – easy to memorize - and frequently sung by children on long bus trips, or Scouting outings. The same verse is repeated, each time with one fewer bottle. The song is completed when the singers reach zero.
Could it be that Merck & CO pharmacists are singing 99 Strains of HPV on the Wall as they prepare to manufacture more vaccines targeting more HPV viral strains? And of course the accounting department is humming the same tune as they realize the income potential and enter projected profits from this new revenue stream. And one wonders if Wall Street is also memorizing the song knowing that stock will not only remain stable but potentially soar.
According to an article that appeared in the January 13, 2011 issue of Drug Discovery and Development, Vaccine Markets A Refuge for Big Pharma, http://www.dddmag.com/news-Vaccine-Markets-A-Refuge-for- ... :
…Gardasil, which was approved for the prevention of four strains of HPV (human papillomavirus), is currently being tested for the prevention of nine more strains.
90 Strains of HPV on the Wall
The article also states: “Human vaccines, earlier considered as a low profit yielding business, have transformed into cash cows for global pharmaceutical giants. Patents for human and animal vaccines accepted by European and US patent authorities totaled nearly 250 in 2007. Prophylactic vaccines (intended to prevent cancer from developing in healthy people) represents the biggest earner in the human vaccines market.”
Oh, yes, Big Pharma is singing 99 Strains of HPV on the Wall – all the way to Wall Street.
Meanwhile, SANE Vax, Inc. keeps finding research and documentation on the scientific research behind the vaccines, the faulty trials and the unethical marketing campaigns – that had adolescent girls singing their award –winning “One Less Girl to Get Cervical Cancer” jingle….
Gardasil. Gardasil. Gardasil. Gardasil.
I want to be one less woman who will battle cervical cancer.
One LESS.
One has to admit – the campaign jingle has similar qualities to 99 Bottles of Beer in the Wall – it has a repetitive format and is easy to memorize. Guess Merck’s public relations firm is also singing 99 Strains of HPV on the Wall as they develop more award-winning marketing campaigns.
Unfortunately, one less girl has sadly turned into One More Girl adversely injured. VAERS statistics as of February are: 21,292 girls (20,377) and boys (309) adversely injured, 94 dead; an estimated 1 to 10% of the population reporting.
21,292 HPV Vaccine Adverse Injuries on the Wall - asking when will the jingle end?
Recently, the mother of a 13-year old injured by the vaccine told a SANE Vax member that when she called 1-800 MERCK – the man on the line admitted that not enough clinical trials were conducted on Gardasil and that her daughter was part of a trial. SANE Vax is outraged by this admission. But this is how Pharma operates with all drugs especially for women. Birth control pills, hormone replacement therapy (HRT), and Gardasil are now known as the largest uncontrolled experiments in medical history.
SANE Vax Inc. is determined to prevent Gardasil from being trialed on innocent children. We are proud to be involved in the production of the groundbreaking ONE MORE GIRL documentary along with Truth About Gardasil.org and ThinkExist Productions http://www.kickstarter.com/projects/1995527181/one-more- ....
The time to get involved is now – we need to stop Merck and their 99 Strains of HPV on the Wall thinking until an independent study on the safety and efficacy of Gardasil has been conducted before more HPV-related vaccines are introduced to the market.
Please donate today. The girls injured by the HPV vaccines want to tell their stories to the world to prevent this type of travesty from ever happening again.
99 Strains of HPV on the Wall
You Take One Down and Pass it Around….
One MORE GIRL on the Wall
For more information, visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Tuesday, February 8, 2011
Italian Vaccine Awareness Group Confronts WHO Pandemic Vaccination Policy
By Norma Erickson
For Georgio Tremante, there is no vaccine controversy, only facts. Georgio and his family lost a son in 1971, another in 1980, and have a third child who was left a quadriplegic with respiratory insufficiency after administration of the Sabin polio vaccine.
His son, Alberto, has had to endure years of hospitalization attached to a respirator because he could no longer breathe on his own. Georgio believes Alberto was saved to show the world an inconvenient truth the pharmaceutical companies would like to bury; vaccines can, and do kill and maim innocent children.
This family has experienced the persecution that comes from trying to expose the truth about vaccination risks. They have maintained their mission in spite of pressure from pharmaceutical companies, medical authorities and government agencies. They have continued to do their research and broadcast the facts about vaccination risks in spite of all they have had to endure. View the results of this family and others like them throughout Italy on a website called, A.L.V. “Holocaust” caused by vaccination practices.
As a result of this group’s efforts, a petition is being circulated calling for an end to mandatory and/or forced vaccinations. They are asking government officials around the world to take a serious look at the science behind vaccination practices and re-assess the safety and efficacy of current vaccination policies and programs. An excerpt from their petition says it all:
“We, the undersigned, as free men and women, we do not recognize the authority of the World Health Organization (WHO) that the general mandate for us to immunization. Our bodies are sovereign territory and are subject to our exclusive self-determination. Any attempt to breach this trust must be interpreted as a violation of a fundamental right.”
The A.L.V. is not alone in their belief. Vaccine safety groups from around the world are united in their efforts to expose the potential risks involved with vaccines and current vaccination practices. Consider some of the events from around the world regarding vaccines:
February 2009, two girls are hospitalized in Spain after Gardasil injections, prompting a recall of 76,000 doses of Merck’s ‘cervical cancer’ vaccine.
April 2010, India halts HPV vaccine demonstration projects as a result of health advocates’ concerns about HPV vaccine safety and ethical violations by the organizations conducting the ‘projects.’
April 2010, Bhutan calls an immediate halt to their HPV vaccination program, scheduled to begin in May, in response to the investigation in India.
August 2010, French authorities ban advertising Gardasil® as a preventive measure for cervical cancer.
September 2010, Scottish health authorities come under fire from vaccine safety advocates for failure to disclose potential risks involved with HPV vaccines.
October 2010, Irish mothers unite to get the truth out about potential risk of Gardasil®.
October 2010, in the United States, SaneVax Inc. requests the FDA rescind the approval of Gardasil® until it is proven safe and effective.
January 2011, British Society for Ecological Medicine organizes a medical conference entitled, “The Health Hazards of Prevention – Vaccinations and Pharmacoprophylaxis.”
These are but a few of the significant developments in the vaccine safety advocate community during the last year.
The World Health Organization assessed the situation properly when they said governments, pharmaceutical companies and health officials need to address parental concerns about vaccine safety.
Parents around the world are not going to sit quietly by as their children are injured or killed because of public policy. Their concerns do, indeed, need to be addressed – not with rhetoric and platitudes – but with sound, scientific evidence.
Please visit our site at http://sanevax.org/
For Georgio Tremante, there is no vaccine controversy, only facts. Georgio and his family lost a son in 1971, another in 1980, and have a third child who was left a quadriplegic with respiratory insufficiency after administration of the Sabin polio vaccine.
His son, Alberto, has had to endure years of hospitalization attached to a respirator because he could no longer breathe on his own. Georgio believes Alberto was saved to show the world an inconvenient truth the pharmaceutical companies would like to bury; vaccines can, and do kill and maim innocent children.
This family has experienced the persecution that comes from trying to expose the truth about vaccination risks. They have maintained their mission in spite of pressure from pharmaceutical companies, medical authorities and government agencies. They have continued to do their research and broadcast the facts about vaccination risks in spite of all they have had to endure. View the results of this family and others like them throughout Italy on a website called, A.L.V. “Holocaust” caused by vaccination practices.
As a result of this group’s efforts, a petition is being circulated calling for an end to mandatory and/or forced vaccinations. They are asking government officials around the world to take a serious look at the science behind vaccination practices and re-assess the safety and efficacy of current vaccination policies and programs. An excerpt from their petition says it all:
“We, the undersigned, as free men and women, we do not recognize the authority of the World Health Organization (WHO) that the general mandate for us to immunization. Our bodies are sovereign territory and are subject to our exclusive self-determination. Any attempt to breach this trust must be interpreted as a violation of a fundamental right.”
The A.L.V. is not alone in their belief. Vaccine safety groups from around the world are united in their efforts to expose the potential risks involved with vaccines and current vaccination practices. Consider some of the events from around the world regarding vaccines:
February 2009, two girls are hospitalized in Spain after Gardasil injections, prompting a recall of 76,000 doses of Merck’s ‘cervical cancer’ vaccine.
April 2010, India halts HPV vaccine demonstration projects as a result of health advocates’ concerns about HPV vaccine safety and ethical violations by the organizations conducting the ‘projects.’
April 2010, Bhutan calls an immediate halt to their HPV vaccination program, scheduled to begin in May, in response to the investigation in India.
August 2010, French authorities ban advertising Gardasil® as a preventive measure for cervical cancer.
September 2010, Scottish health authorities come under fire from vaccine safety advocates for failure to disclose potential risks involved with HPV vaccines.
October 2010, Irish mothers unite to get the truth out about potential risk of Gardasil®.
October 2010, in the United States, SaneVax Inc. requests the FDA rescind the approval of Gardasil® until it is proven safe and effective.
January 2011, British Society for Ecological Medicine organizes a medical conference entitled, “The Health Hazards of Prevention – Vaccinations and Pharmacoprophylaxis.”
These are but a few of the significant developments in the vaccine safety advocate community during the last year.
The World Health Organization assessed the situation properly when they said governments, pharmaceutical companies and health officials need to address parental concerns about vaccine safety.
Parents around the world are not going to sit quietly by as their children are injured or killed because of public policy. Their concerns do, indeed, need to be addressed – not with rhetoric and platitudes – but with sound, scientific evidence.
Please visit our site at http://sanevax.org/
Wednesday, February 2, 2011
Gardasil Vaccination: Evaluating The Risks Versus Benefits
Are the risks of adverse events related to GARDASIL the HPV Vaccine greater than the benefits? As the adverse events reported in VAERS escalate and the death count increases, parents should investigate the benefits before deciding to vaccinate.
Feb 02, 2011 – All drugs are associated with some risks of adverse reactions and vaccines are no exception. In weighing risks versus benefits, one has to keep in mind that vaccines represent a special category of drugs since they are generally given to healthy individuals.
If there are uncertain benefits from a vaccine, only a small level of risk of harmful effects may be acceptable. If the benefits are certain, then a greater risk of side effects may be tolerated. Here I review the current evidence which indicates that the former case applies to Gardasil, the quadrivalent human papillomavirus (qHPV) vaccine:
1) The efficacy of Gardasil in preventing cervical cancer has not been demonstrated and the marketing campaign has been misleading. The efficacy of Gardasil remains unsubstantiated since the vaccine hasn’t been adequately tested on the primary age group to which it is currently given.
Merck promoted Gardasil primarily as a vaccine against cervical cancer, rather than promoting it as a vaccine against HPV infection or sexually transmitted diseases 1.
According to recent reports published in two highly respected scientific journals, Nature Biotechnology and Journal of American Medical Association (JAMA):
“Most genital infections are asymptomatic and resolve spontaneously, but the virus can persist and cause precancerous lesions that can become malignant over the subsequent 20-30 years.“ (Nature Biotechnology, 2007 2)
“So how should a parent, physician, politician, or anyone else decide whether it is a good thing to give young girls a vaccine that partly prevents infection caused by a sexually transmitted disease (HPV infection), an infection that in a few cases will cause cancer 20 to 40 years from now? (JAMA, 2009 3).
The fact is that malignant cervical cancer takes decades to develop 2 3 and yet the longest clinical trial on Gardasil was only four years in duration 4. In other words, Gardasil was never shown to prevent cervical cancer [emphasis added]. Furthermore, in all clinical trials conducted by Merck the cervical intraepithelial neoplasia (CIN) 2/3 precancerous lesion was used as the efficacy endpoint for evaluating the Gardasil 4. What is the problem with using the CIN 2/3 lesion as the standard for efficacy? First, if the marketing claim for Gardasil is that the vaccine “protects against cervical cancer” 1 2 5, then cervical cancer should have been used as the endpoint for efficacy, not a surrogate marker such as a CIN 2/3 precancerous lesion [emphasis added].
Second, in the natural course of cervical cancer, only a small fraction of the CIN 2 lesions will progress to CIN 3 lesions and only a small fraction of CIN 3 lesions will eventually progress to cervical cancer 6.
Furthermore, even CIN 3 lesions are heterogeneous (there are early small lesions and old advanced lesions and we do not know what proportion of the small lesions, which serve as clinical endpoints in current studies, would persist to become large, advanced CIN3 lesions) 7.
Therefore, in any female population (and that includes those who have undergone Gardasil clinical trials) there are many more CIN 2 lesions than a combination of CIN 3 lesions and cervical cancers. As a result, the vast majority of the “CIN 2/3 or worse” cases used for evaluation of efficacy, and listed in Merck‟s report to FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC Background Document on Gardasil HPV Quadrivalent Vaccine 8), must have been CIN 2 lesions.
In a review of the literature from 1950-1992, it was noted that 60% of CIN 1 lesions regressed, 30% persisted, 10% progressed to CIN 3, and only 1% progressed to invasive cancer. The corresponding approximations for CIN 2 were 40%, 40%, 20%, and 5%, respectively. The likelihood of CIN 3 regressing was 33% and that of progressing to invasive cancer was greater than 12% 6.
The author of the study, Andrew G Östör, MD, from the Departments of Obstetrics and Gynaecology and Pathology, University of Melbourne noted 6:
“It is obvious from the above figures that the probability of an atypical epithelium becoming invasive increases with the severity of the atypia, but does not occur in every case. Even the higher degrees of atypia may regress in a significant proportion of cases. As morphology by itself does not predict which lesion will progress or regress, future efforts should seek factors other than morphological to determine the prognosis in individual patients.” [emphasis added]
The above remark leads us to a third reason why a surrogate morphological marker is not an adequate endpoint for assessing the efficacy of cervical cancer vaccines 9:
“CIN 2 is not a true biologic entity but an equivocal diagnosis of pre-cancer, representing an admixture of HPV infection and pre-cancer. The existence of CIN 2 biopsy results as a clinical entity may be the consequence of the inaccuracies of colposcopy and colposcopically directed biopsy, which could result in less than-perfect representation of the underlying disease state.” [empahsis added]
Furthermore, the same report by the National Cancer Institute (NCI 9) states that:
“That CIN2 is the least reproducible of all histopathologic diagnoses may in part reflect sampling error…”
Finally, according to second report by the NCI 10:
“Approximately 40% of undiagnosed CIN 2 will regress over two years” (this also precisely corroborates the findings of the study by Östör)
Gardasil is marketed as the vaccine that prevents cervical cancer 1 2 5.This statement is incorrect. Based on the above NCI findings, we can conclude that the data presented in the VRBPAC Background Document on Gardasil HPV Quadrivalent Vaccine 8 only supports the claim that Gardasil can prevent “an equivocal diagnosis of pre-cancer, representing an admixture of HPV infection and pre-cancer” - about half of which are self-reversing to normal cases and not reflect actual cervical cancer. [emphasis added]
There was yet another important oversight in assessing the efficacy of Gardasil. Most cervical cancers are believed to be linked to infection with genital HPV types 6, 11, 16, and 18 2 3 11. According to NCI, the only reliable HPV genotyping method is a “PCR system with short target sequences” 12 or alternatively, “ ’sentinel-base’ genotyping by PCR” 13 Ironically, these HPV genotyping methods were never used to determine the HPV type associated with precancerous lesions in the clinical trials for evaluation of the efficacy of Gardasil to prevent type-specific HPV infections.
2) Cervical cancer is a rare disease in developed countries which invalidates the recommendations for universal immunization with any HPV vaccine. The incidence of cervical cancer has dropped substantially since implementation of regular Pap screening procedures. Currently, in the US, the death rate from cervical cancer (2.4/100,000 women) is lower than the rate of reported serious adverse events, including death, from Gardasil (3.34/100,000 doses distributed)
The severity of cervical cancer should not be undermined. Advanced cervical cancer is a deadly disease, especially in areas where the resources and infrastructure to fully implement
To continue reading the story, go to http://sanevax.org/news-blog/?p=1353.
Story by Lucija Tomljenovic, PhD, contributing author for SANEVAX, INC.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Feb 02, 2011 – All drugs are associated with some risks of adverse reactions and vaccines are no exception. In weighing risks versus benefits, one has to keep in mind that vaccines represent a special category of drugs since they are generally given to healthy individuals.
If there are uncertain benefits from a vaccine, only a small level of risk of harmful effects may be acceptable. If the benefits are certain, then a greater risk of side effects may be tolerated. Here I review the current evidence which indicates that the former case applies to Gardasil, the quadrivalent human papillomavirus (qHPV) vaccine:
1) The efficacy of Gardasil in preventing cervical cancer has not been demonstrated and the marketing campaign has been misleading. The efficacy of Gardasil remains unsubstantiated since the vaccine hasn’t been adequately tested on the primary age group to which it is currently given.
Merck promoted Gardasil primarily as a vaccine against cervical cancer, rather than promoting it as a vaccine against HPV infection or sexually transmitted diseases 1.
According to recent reports published in two highly respected scientific journals, Nature Biotechnology and Journal of American Medical Association (JAMA):
“Most genital infections are asymptomatic and resolve spontaneously, but the virus can persist and cause precancerous lesions that can become malignant over the subsequent 20-30 years.“ (Nature Biotechnology, 2007 2)
“So how should a parent, physician, politician, or anyone else decide whether it is a good thing to give young girls a vaccine that partly prevents infection caused by a sexually transmitted disease (HPV infection), an infection that in a few cases will cause cancer 20 to 40 years from now? (JAMA, 2009 3).
The fact is that malignant cervical cancer takes decades to develop 2 3 and yet the longest clinical trial on Gardasil was only four years in duration 4. In other words, Gardasil was never shown to prevent cervical cancer [emphasis added]. Furthermore, in all clinical trials conducted by Merck the cervical intraepithelial neoplasia (CIN) 2/3 precancerous lesion was used as the efficacy endpoint for evaluating the Gardasil 4. What is the problem with using the CIN 2/3 lesion as the standard for efficacy? First, if the marketing claim for Gardasil is that the vaccine “protects against cervical cancer” 1 2 5, then cervical cancer should have been used as the endpoint for efficacy, not a surrogate marker such as a CIN 2/3 precancerous lesion [emphasis added].
Second, in the natural course of cervical cancer, only a small fraction of the CIN 2 lesions will progress to CIN 3 lesions and only a small fraction of CIN 3 lesions will eventually progress to cervical cancer 6.
Furthermore, even CIN 3 lesions are heterogeneous (there are early small lesions and old advanced lesions and we do not know what proportion of the small lesions, which serve as clinical endpoints in current studies, would persist to become large, advanced CIN3 lesions) 7.
Therefore, in any female population (and that includes those who have undergone Gardasil clinical trials) there are many more CIN 2 lesions than a combination of CIN 3 lesions and cervical cancers. As a result, the vast majority of the “CIN 2/3 or worse” cases used for evaluation of efficacy, and listed in Merck‟s report to FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC Background Document on Gardasil HPV Quadrivalent Vaccine 8), must have been CIN 2 lesions.
In a review of the literature from 1950-1992, it was noted that 60% of CIN 1 lesions regressed, 30% persisted, 10% progressed to CIN 3, and only 1% progressed to invasive cancer. The corresponding approximations for CIN 2 were 40%, 40%, 20%, and 5%, respectively. The likelihood of CIN 3 regressing was 33% and that of progressing to invasive cancer was greater than 12% 6.
The author of the study, Andrew G Östör, MD, from the Departments of Obstetrics and Gynaecology and Pathology, University of Melbourne noted 6:
“It is obvious from the above figures that the probability of an atypical epithelium becoming invasive increases with the severity of the atypia, but does not occur in every case. Even the higher degrees of atypia may regress in a significant proportion of cases. As morphology by itself does not predict which lesion will progress or regress, future efforts should seek factors other than morphological to determine the prognosis in individual patients.” [emphasis added]
The above remark leads us to a third reason why a surrogate morphological marker is not an adequate endpoint for assessing the efficacy of cervical cancer vaccines 9:
“CIN 2 is not a true biologic entity but an equivocal diagnosis of pre-cancer, representing an admixture of HPV infection and pre-cancer. The existence of CIN 2 biopsy results as a clinical entity may be the consequence of the inaccuracies of colposcopy and colposcopically directed biopsy, which could result in less than-perfect representation of the underlying disease state.” [empahsis added]
Furthermore, the same report by the National Cancer Institute (NCI 9) states that:
“That CIN2 is the least reproducible of all histopathologic diagnoses may in part reflect sampling error…”
Finally, according to second report by the NCI 10:
“Approximately 40% of undiagnosed CIN 2 will regress over two years” (this also precisely corroborates the findings of the study by Östör)
Gardasil is marketed as the vaccine that prevents cervical cancer 1 2 5.This statement is incorrect. Based on the above NCI findings, we can conclude that the data presented in the VRBPAC Background Document on Gardasil HPV Quadrivalent Vaccine 8 only supports the claim that Gardasil can prevent “an equivocal diagnosis of pre-cancer, representing an admixture of HPV infection and pre-cancer” - about half of which are self-reversing to normal cases and not reflect actual cervical cancer. [emphasis added]
There was yet another important oversight in assessing the efficacy of Gardasil. Most cervical cancers are believed to be linked to infection with genital HPV types 6, 11, 16, and 18 2 3 11. According to NCI, the only reliable HPV genotyping method is a “PCR system with short target sequences” 12 or alternatively, “ ’sentinel-base’ genotyping by PCR” 13 Ironically, these HPV genotyping methods were never used to determine the HPV type associated with precancerous lesions in the clinical trials for evaluation of the efficacy of Gardasil to prevent type-specific HPV infections.
2) Cervical cancer is a rare disease in developed countries which invalidates the recommendations for universal immunization with any HPV vaccine. The incidence of cervical cancer has dropped substantially since implementation of regular Pap screening procedures. Currently, in the US, the death rate from cervical cancer (2.4/100,000 women) is lower than the rate of reported serious adverse events, including death, from Gardasil (3.34/100,000 doses distributed)
The severity of cervical cancer should not be undermined. Advanced cervical cancer is a deadly disease, especially in areas where the resources and infrastructure to fully implement
To continue reading the story, go to http://sanevax.org/news-blog/?p=1353.
Story by Lucija Tomljenovic, PhD, contributing author for SANEVAX, INC.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Monday, January 31, 2011
Estrogen is to Cancer what Fertilizer is to Wheat
Estrogen & HPV Stimulation – Did Merck Conduct the Studies for Gardasil?
PRLog (Press Release) – Jan 31, 2011 – It appears history has repeated itself many times since January 1970, when a Senate testimony hearing on the safety and efficacy of the first birth control pill was conducted after pressure from women’s groups who were concerned about the side effects of the high dose estrogen in the pills. In 1970, women’s testimonies were disregarded. Concerned delegates were relegated to sit in the balcony during the hearing.
A Hearing without Women's Voices
In January 1970 experts assembled in the stately Senate chamber and began giving their testimony on the hazards of the Pill. Alice Wolfson, a member of the radical collective D.C. Women's Liberation, was sitting in the audience listening to the experts. Her group had come to the hearings because they had all taken the Pill at one time or another and experienced adverse side effects. The group was outraged that their doctors had never informed them of the risks when they prescribed the Pill. As they sat in the chamber and heard one male witness after another describe serious health risks, they were furious that there wasn't a single woman who had taken the Pill there to testify.
Outrage on Two Accounts
After hearing one expert say, "Estrogen is to cancer what fertilizer is to wheat," the women spectators could no longer contain their anger. They stood up and started hurling questions at the men on the dais. The feminists set the room abuzz when they demanded, "Why are you using women as guinea pigs?" and "Why are you letting the drug companies murder us for their profit and convenience?" When told by Senator Nelson to sit down and remain quiet, they retorted, "We are not going to sit quietly! We don't think the hearings are more important than our lives!" 1.
HRT – Risks Outweigh Benefits
Hormone replacement Therapy (HRT) was on the market over 30 years before the Women’s Health Initiative conducted an independent study. “Attitudes towards HRT changed in 2002 following the announcement by the Women's Health Initiative of the National Institutes of Health that those receiving the treatment (Prempro) in the main part of their study had a larger incidence of breast cancer, heart attacks and strokes. The WHI findings were reconfirmed in a larger national study done in the UK, known as The Million Women Study. As a result of these findings, the number of women taking hormone treatment dropped precipitously.” 2.
Now hundreds of lawsuits worth millions of dollars have been filed against pharmaceutical companies as a result of women getting breast cancer as a result of HRT.
Not long after, a line of lower dose extended cycle estrogen birth control pills flooded the market and were prescribed to adolescent girls for a multitude of ‘ailments’ other than the prevention of pregnancy. The jury is out on the long term effects of the extended OC’s, but some are beginning to question their causal relationship to cancer.
May 2006, Gardasil made its debut on the market. But, according to the FDA’s Cancer Liaison Program, they are unaware of any studies regarding ‘Gardasil, cancer, and HPV stimulation.’
During the last two months, results of two disconcerting studies have been released: The association of hormonal contraceptive use and HPV prevalence, International Journal of Cancer (IJC); and Estrogen May Play Role in Rising Rates of Head, Neck Cancer; Health Day News.
The IJC study reported that “Women diagnosed with cervical cancer report longer duration and more recent use of combined oral contraceptives (COCs). It is unclear whether COC use is associated with upstream events of human papillomavirus (HPV) infection prior to development of clinical disease.” The studies objective…“was to assess the association of contraceptive use on the risk for prevalent HPV infection in a cohort of long-term hormonal contraceptive (HC) users.”
The authors found: a demonstratable “association between the use of COCs for >6 years and prevalent HPV infection among 20- to 37-year-old women from Thailand after controlling for sexual behavior and cytological abnormalities. This finding is in agreement with other smaller cross-sectional studies conducted among college age women and women 20–29 years of age who report COC use for >4 years.” The summary concluded that “observed that long-term use of COCs of >6 years is associated with an increased risk of prevalent HPV infection in a cohort of HC and NHC users in Thailand.” 3.
For months news headlines reported on the association between HPV and head and neck cancers suggesting that Gardasil may be a preventive for these cancers as well. However, Health Day News reported that estrogen stimulation may indeed be behind the HPV stimulation for head and neck cancers.
“Rates of head and neck cancer are rising among some groups of people, including young women without any known risk factors. Now, a study suggests that estrogen may help the cancer spread by boosting the movement of precancerous cells in the mouth.” 4.
SANE Vax believes that these two studies warrant more examination. An independent study of the relationship between estrogen, HPV, cancer and Gardasil needs to be conducted immediately. Over 382 reports of abnormal pap smears post-HPV vaccination –some including cervical cancer – have already been reported to VAERS.
Estrogen is to cancer what fertilizer is to wheat. We are now in a third and fourth generation of adolescent women whose mothers and grandmothers took oral contraceptives and hormone replacement therapy. Estrogen dominance in the form of mimickers from food, plastics and household solvents, and water sources is a growing concern.
SANE Vax Inc. is not going to sit by quietly waiting for studies to be conducted on the safety and efficacy of Gardasil. We will fight for science-based medicine until women and children are no longer used as guinea pigs for profiteering pharmaceutical companies.
Source:
1. American Experience/The Pill - http://www.pbs.org/wgbh/amex/pill/peopleevents/e_hearing ...
2. Hormone Replacement Therapy; http://en.wikipedia.org/wiki/Hormone_replacement_therapy ...
3. The association of hormonal contraceptive use and HPV prevalence; International Journal of Cancer; 26 Oct 2010; http://onlinelibrary.wiley.com/doi/10.1002/ijc.25628/full
4. Estrogen May Play Role in Rising Rates of Head, Neck Cancer; Health Day News; January 4, 2011; http://health.usnews.com/health-news/family-health/cancer/articles/2011/01/04/estrogen-may-play-role-in-rising-rates-of-head-neck-cancer?msg=1
Please visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
PRLog (Press Release) – Jan 31, 2011 – It appears history has repeated itself many times since January 1970, when a Senate testimony hearing on the safety and efficacy of the first birth control pill was conducted after pressure from women’s groups who were concerned about the side effects of the high dose estrogen in the pills. In 1970, women’s testimonies were disregarded. Concerned delegates were relegated to sit in the balcony during the hearing.
A Hearing without Women's Voices
In January 1970 experts assembled in the stately Senate chamber and began giving their testimony on the hazards of the Pill. Alice Wolfson, a member of the radical collective D.C. Women's Liberation, was sitting in the audience listening to the experts. Her group had come to the hearings because they had all taken the Pill at one time or another and experienced adverse side effects. The group was outraged that their doctors had never informed them of the risks when they prescribed the Pill. As they sat in the chamber and heard one male witness after another describe serious health risks, they were furious that there wasn't a single woman who had taken the Pill there to testify.
Outrage on Two Accounts
After hearing one expert say, "Estrogen is to cancer what fertilizer is to wheat," the women spectators could no longer contain their anger. They stood up and started hurling questions at the men on the dais. The feminists set the room abuzz when they demanded, "Why are you using women as guinea pigs?" and "Why are you letting the drug companies murder us for their profit and convenience?" When told by Senator Nelson to sit down and remain quiet, they retorted, "We are not going to sit quietly! We don't think the hearings are more important than our lives!" 1.
HRT – Risks Outweigh Benefits
Hormone replacement Therapy (HRT) was on the market over 30 years before the Women’s Health Initiative conducted an independent study. “Attitudes towards HRT changed in 2002 following the announcement by the Women's Health Initiative of the National Institutes of Health that those receiving the treatment (Prempro) in the main part of their study had a larger incidence of breast cancer, heart attacks and strokes. The WHI findings were reconfirmed in a larger national study done in the UK, known as The Million Women Study. As a result of these findings, the number of women taking hormone treatment dropped precipitously.” 2.
Now hundreds of lawsuits worth millions of dollars have been filed against pharmaceutical companies as a result of women getting breast cancer as a result of HRT.
Not long after, a line of lower dose extended cycle estrogen birth control pills flooded the market and were prescribed to adolescent girls for a multitude of ‘ailments’ other than the prevention of pregnancy. The jury is out on the long term effects of the extended OC’s, but some are beginning to question their causal relationship to cancer.
May 2006, Gardasil made its debut on the market. But, according to the FDA’s Cancer Liaison Program, they are unaware of any studies regarding ‘Gardasil, cancer, and HPV stimulation.’
During the last two months, results of two disconcerting studies have been released: The association of hormonal contraceptive use and HPV prevalence, International Journal of Cancer (IJC); and Estrogen May Play Role in Rising Rates of Head, Neck Cancer; Health Day News.
The IJC study reported that “Women diagnosed with cervical cancer report longer duration and more recent use of combined oral contraceptives (COCs). It is unclear whether COC use is associated with upstream events of human papillomavirus (HPV) infection prior to development of clinical disease.” The studies objective…“was to assess the association of contraceptive use on the risk for prevalent HPV infection in a cohort of long-term hormonal contraceptive (HC) users.”
The authors found: a demonstratable “association between the use of COCs for >6 years and prevalent HPV infection among 20- to 37-year-old women from Thailand after controlling for sexual behavior and cytological abnormalities. This finding is in agreement with other smaller cross-sectional studies conducted among college age women and women 20–29 years of age who report COC use for >4 years.” The summary concluded that “observed that long-term use of COCs of >6 years is associated with an increased risk of prevalent HPV infection in a cohort of HC and NHC users in Thailand.” 3.
For months news headlines reported on the association between HPV and head and neck cancers suggesting that Gardasil may be a preventive for these cancers as well. However, Health Day News reported that estrogen stimulation may indeed be behind the HPV stimulation for head and neck cancers.
“Rates of head and neck cancer are rising among some groups of people, including young women without any known risk factors. Now, a study suggests that estrogen may help the cancer spread by boosting the movement of precancerous cells in the mouth.” 4.
SANE Vax believes that these two studies warrant more examination. An independent study of the relationship between estrogen, HPV, cancer and Gardasil needs to be conducted immediately. Over 382 reports of abnormal pap smears post-HPV vaccination –some including cervical cancer – have already been reported to VAERS.
Estrogen is to cancer what fertilizer is to wheat. We are now in a third and fourth generation of adolescent women whose mothers and grandmothers took oral contraceptives and hormone replacement therapy. Estrogen dominance in the form of mimickers from food, plastics and household solvents, and water sources is a growing concern.
SANE Vax Inc. is not going to sit by quietly waiting for studies to be conducted on the safety and efficacy of Gardasil. We will fight for science-based medicine until women and children are no longer used as guinea pigs for profiteering pharmaceutical companies.
Source:
1. American Experience/The Pill - http://www.pbs.org/wgbh/amex/pill/peopleevents/e_hearing ...
2. Hormone Replacement Therapy; http://en.wikipedia.org/wiki/Hormone_replacement_therapy ...
3. The association of hormonal contraceptive use and HPV prevalence; International Journal of Cancer; 26 Oct 2010; http://onlinelibrary.wiley.com/doi/10.1002/ijc.25628/full
4. Estrogen May Play Role in Rising Rates of Head, Neck Cancer; Health Day News; January 4, 2011; http://health.usnews.com/health-news/family-health/cancer/articles/2011/01/04/estrogen-may-play-role-in-rising-rates-of-head-neck-cancer?msg=1
Please visit our site at http://sanevax.org/.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Saturday, January 29, 2011
One More Girl film documentary to unveil the truth about HPV vaccines
Please support the effort to reveal the stories of injury and death related to the HPV Vaccines Gardasil and Cervarix.
PRLog (Press Release) – Jan 29, 2011 – Two film making brothers and prominent advocacy groups have announced the planned production of a provocative new documentary film about HPV vaccines titled "One More Girl". The just issued press release announcing the film and seeking funding donations promises that the film will reveal to the world a trail of death, injured young girls and devastated families following HPV vaccinations. The film also plans to take a critical look at the social and political trail of deception which enabled vaccines described as "medical experiments" to get by the world's health regulatory agencies.
Film making brothers Ryan and David Richardson decided to make the film after witnessing the adverse reaction and long road to recovery of their 18-year-old sister Donielle Richardson. Her experience led the Richardson family to research other Gardasil girl injuries. Their discoveries resulted in the brothers' decision to create a powerful documentary film to prevent similar travesties from happening to other girls and their families.
"One More Girl" represents a collaboration between two brothers whose sister was injured by the HPV vaccine Gardasil and two prominent advocacy groups involved in exposing the truth about HPV vaccines - TruthAboutGardasil.org and S.A.N.E.Vax, Inc..
The Richardson brothers plan to devote a large portion of their film to a platform for several other young women and their families to share their experiences in their own words. The first-hand testimonials promise to be some of the most powerful and moving segments of the film.
Viewers will be able to watch the girls and their families share their dismay and sense of betrayal for believing the pharmaceutical and medical industries marketing about the safety of HPV vaccines and their use for the prevention of cervical cancer. Included in the testimonials are stories of anguish, loss of innocence, and the guilt felt by many mothers who trusted the vaccine makers and the advice of their doctors. Viewers will also learn how financially devastating it has been for many families to try to find cures for the illnesses their daughters became stricken with after they were vaccinated.
The Richardson brothers' film making company, ThinkExist Productions, is working in conjunction with the advocacy groups to include the history, research, and data both organizations have compiled over the last four years. Combined, the organization's global networks include concerned activists in 120 countries and every state in the U.S.
A preview of "One More Girl", which is being funded largely by public donations, can currently be found on both the TruthAboutGardasil and S.A.N.E.Vax sites as well as the Kick Starter - Fund & Follow Creativity website at http://www.kickstarter.com/projects/1995527181/one-more- ....
Kick Starter is a unique site for film producers and aficionados to preview documentary concepts and donate funds for completion of the films.
It is hoped that funding needed for the film will be raised within 90 days and current plans call for beginning full production during the second quarter of 2011 with a tentative release date of the summer of 2012. ThinkExist Productions,TruthAboutGardasil and SA.N.E.Vax. plan to market "One More Girl" globally and enter the film into various film festivals.
According to the latest VAERS figures, there have been 21,113 adverse events reported for HPV vaccines thus far, including 89 deaths and 692 disabilities. The reports also show 8,617 emergency room visits, 2,092 hospitalizations and 4,396 instances where the victims did not recover from their injuries.
"One More Girl" promises to open the eyes of viewers around the world to the truth about HPV vaccines. The stories and revelations in the film are sure to fill many of those eyes with tears of sadness and anger.
For more information on this topic see “The journey of a Gardasil victim's mother from trusting vaccines to vaccine activist” at http://www.tbyil.com/Vaccine_Victim_Mom_Activist.htm and “Gardasil Exposed - Deadly vaccine pushed on millions of young boys and girls worldwide” at http://www.naturalnews.com/030991_Gardasil_vaccine.html.
Please visit our site at http://sanevax.org/ .
Tony Isaacs, Contributing Author, SaneVax Inc.
Tony Isaacs, is a natural health author, advocate and researcher who hosts The Best Years in Life website http://www.tbyil.com/ for baby boomers and others wishing to avoid prescription drugs and mainstream managed illness and live longer, healthier and happier lives naturally. Mr. Isaacs is the author of books and articles about natural health, longevity and beating cancer including "Cancer's Natural Enemy" and is working on a major book project due to be published in 2011.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
PRLog (Press Release) – Jan 29, 2011 – Two film making brothers and prominent advocacy groups have announced the planned production of a provocative new documentary film about HPV vaccines titled "One More Girl". The just issued press release announcing the film and seeking funding donations promises that the film will reveal to the world a trail of death, injured young girls and devastated families following HPV vaccinations. The film also plans to take a critical look at the social and political trail of deception which enabled vaccines described as "medical experiments" to get by the world's health regulatory agencies.
Film making brothers Ryan and David Richardson decided to make the film after witnessing the adverse reaction and long road to recovery of their 18-year-old sister Donielle Richardson. Her experience led the Richardson family to research other Gardasil girl injuries. Their discoveries resulted in the brothers' decision to create a powerful documentary film to prevent similar travesties from happening to other girls and their families.
"One More Girl" represents a collaboration between two brothers whose sister was injured by the HPV vaccine Gardasil and two prominent advocacy groups involved in exposing the truth about HPV vaccines - TruthAboutGardasil.org and S.A.N.E.Vax, Inc..
The Richardson brothers plan to devote a large portion of their film to a platform for several other young women and their families to share their experiences in their own words. The first-hand testimonials promise to be some of the most powerful and moving segments of the film.
Viewers will be able to watch the girls and their families share their dismay and sense of betrayal for believing the pharmaceutical and medical industries marketing about the safety of HPV vaccines and their use for the prevention of cervical cancer. Included in the testimonials are stories of anguish, loss of innocence, and the guilt felt by many mothers who trusted the vaccine makers and the advice of their doctors. Viewers will also learn how financially devastating it has been for many families to try to find cures for the illnesses their daughters became stricken with after they were vaccinated.
The Richardson brothers' film making company, ThinkExist Productions, is working in conjunction with the advocacy groups to include the history, research, and data both organizations have compiled over the last four years. Combined, the organization's global networks include concerned activists in 120 countries and every state in the U.S.
A preview of "One More Girl", which is being funded largely by public donations, can currently be found on both the TruthAboutGardasil and S.A.N.E.Vax sites as well as the Kick Starter - Fund & Follow Creativity website at http://www.kickstarter.com/projects/1995527181/one-more- ....
Kick Starter is a unique site for film producers and aficionados to preview documentary concepts and donate funds for completion of the films.
It is hoped that funding needed for the film will be raised within 90 days and current plans call for beginning full production during the second quarter of 2011 with a tentative release date of the summer of 2012. ThinkExist Productions,TruthAboutGardasil and SA.N.E.Vax. plan to market "One More Girl" globally and enter the film into various film festivals.
According to the latest VAERS figures, there have been 21,113 adverse events reported for HPV vaccines thus far, including 89 deaths and 692 disabilities. The reports also show 8,617 emergency room visits, 2,092 hospitalizations and 4,396 instances where the victims did not recover from their injuries.
"One More Girl" promises to open the eyes of viewers around the world to the truth about HPV vaccines. The stories and revelations in the film are sure to fill many of those eyes with tears of sadness and anger.
For more information on this topic see “The journey of a Gardasil victim's mother from trusting vaccines to vaccine activist” at http://www.tbyil.com/Vaccine_Victim_Mom_Activist.htm and “Gardasil Exposed - Deadly vaccine pushed on millions of young boys and girls worldwide” at http://www.naturalnews.com/030991_Gardasil_vaccine.html.
Please visit our site at http://sanevax.org/ .
Tony Isaacs, Contributing Author, SaneVax Inc.
Tony Isaacs, is a natural health author, advocate and researcher who hosts The Best Years in Life website http://www.tbyil.com/ for baby boomers and others wishing to avoid prescription drugs and mainstream managed illness and live longer, healthier and happier lives naturally. Mr. Isaacs is the author of books and articles about natural health, longevity and beating cancer including "Cancer's Natural Enemy" and is working on a major book project due to be published in 2011.
# # #
THE SANE VAX MISSION is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine.
Subscribe to:
Posts (Atom)